Lacosamide Solution
Product Images NDC 68462-940

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 68462-940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamide200mlbottle (Lacosamide200mlbottle)

Label for Lacosamide Oral Solution USP 10 mg/mL, an oral solution supplied in a 200 mL bottle. The label includes dosing, storage instructions, and warnings. Manufactured by MSN Pharmaceuticals Inc. and distributed by Glenmark Pharmaceuticals Inc., USA. The NDC code is 68462-940.*

FDA Label Image

Lacosamidefig1 (Lacosamidefig1)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose,' comparing percent seizure reduction between placebo and various doses of Lacosamide across three studies. The vertical axis shows seizure reduction percentages, with Lacosamide doses ranging from 200 to 600 mg/day, demonstrating higher median seizure reductions than placebo in each study.*

FDA Label Image

Lacosamidefig2 (Lacosamidefig2)

A line graph titled 'Proportion of Patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4'. The x-axis represents percent of patients decreasing from 100% to 0%, and the y-axis shows responder rate ranging from -100% (worsening) to 100% (improvement). Four lines compare placebo (N=359) and lacosamide 200 mg/day (N=247), 400 mg/day (N=266 and N=202) groups, illustrating patient responder rates across these groups.*

FDA Label Image

Lacosamidefig3 (Lacosamidefig3)

A Kaplan-Meier survival curve showing the proportion of patients over time (days) for two groups: Placebo (solid line) and Vimpat (dashed line). The plot includes risk numbers at time intervals and statistics such as p-value, hazard ratio, and confidence interval. The y-axis represents the proportion of patients, and the x-axis represents time in days.*

FDA Label Image

Lacosamidestructure (Lacosamidestructure)

Chemical structure of lacosamide, showing its molecular arrangement with functional groups and bonds as part of the medication lacosamide used in oral solution form.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.